Some investors in North America will finally be able to access a Bitcoin exchange traded fund. Just not in the United States. Late Thursday, Canadian regulators approved the Purpose Bitcoin ETF , which will trade on the Toronto Stock Exchange ( TSE ) under the ticker ‘ BTCC ’. “This ETF is an alternative mutual fund.
Both the healthcare and technology sectors appear poised for more upside in 2021. With the ALPS Disruptive Technologies ETF (CBOE: DTEC) , investors don’t have to choose between the two. DTEC tracks the Indxx Disruptive Technologies Index, which identifies companies using disruptive technologies across ten thematic areas, including Healthcare Innovation, Internet of Things, Clean Energy and Smart Grid, Cloud Computing, Data and Analytics, FinTech, Robotics, Artificial Intelligence, Cybersecurity, 3D Printing, and Mobile Payments.
One of the hottest names in the investing world in 2020 was Cathie Wood, CEO of Ark Funds. The legendary fund manager had some of the best performing ETFs of the year and also saw strong inflows of money put into her actively managed funds.
Social distancing is helping to push the needle toward more telemedicine, which bodes well for ETFs like the Global X Telemedicine and Digital Health ETF (EDOC) . The fund is up 9% to start 2021. “Once considered to be merely a novel way to connect doctors with patients, telemedicine now is recognized as an essential tool in the fight to overcome Covid-19,” a Forbes article noted. “Since the start of this pandemic, there has been a nationwide push for treating non-emergency physical and mental illnesses with virtual office visits.
ARK Invest has identified five innovation platforms that are evolving today and generating new technological breakthroughs. Companies that are leading and benefiting from these technologies could present opportunities for long-term growth and capital appreciation.
There still isn’t a bitcoin exchange-traded fund in the U.S. When that’s going to change is up for considerable debate, but in the meantime, investors have some other avenues to consider, including blockchain exchange-traded funds .
The genomics space is rapidly innovating. The ARK Genomic Revolution Multi-Sector Fund ( ARKG ) makes accessing innovation much easier. For investors, ARKG’s active management and utility are vital because the fund is flexible and able to capitalize on genomics advancements more rapidly than index-based rivals.
The accelerating adoption of digital technologies in emerging economies will open growth opportunities for investors. “With the emergence of COVID-19, we saw an unprecedented step up in the pace of new adoption and integration, as the need to communicate and conduct business digitally became an imperative rather than simply a choice.
Tesla stock is surging on Friday, up 7.6%, and headed toward $900 per share, as it looks to close out an unprecedented 11th trading day higher. In addition to boosting ETFs like the ARK Industrial Innovation ETF (NYSEArca: ARKQ), Tesla stock is up 36% over its 11 sessions of gains, the longest winning streak on record.
It’s now the largest actively managed exchange traded of any variety, and its one of the best-performing ETFs this year, active or passive. The ARK Innovation ETF ( ARKK ) didn’t get here by chance. ARKK is often highlighted for being an early ETF advocate for Tesla ( NASDAQ : TSLA ). The case for Tesla upside remains strong because of continuous advancements in EV. “Electric vehicles may cost about the same as their gas-guzzling brethren in just three or four years — and only get cheaper from there,” reports David Baker for Bloomberg .
Amid an already hectic trading session, as investors contend with larger-than-normal trading volumes due to quadruple witching, the phenomenon when options and futures on indexes
INTRODUCING 3 NEW MEMBERS OF THE INVESCO QQQ FAMILY
The WisdomTree U.S. Quality Dividend Growth ETF ( DGRW ) focuses on the dividend growth & quality factors and could be uniquely positioned to outperform in a post-vaccine world Positioning For The Re-Opening Rally The news of Pfizer’s potential coronavirus vaccine yielding very encouraging results in the early findings of its clinical trial was more than enough to send investors racing into risk assets betting that a full economic recovery could be on the way.
Instead, DGRW looks at long-term earnings growth expectations as a proxy for a company’s ability to continue paying and growing its dividend over time.
ARKG includes companies that merge healthcare with technology to capitalize on the revolution in genomic sequencing.
“CRISPR’s addressable market in the monogenic disease space could scale to $75B annually with nearly $2T in latent demand from unaddressed populations.
